70 likes | 83 Vues
The dental biomaterials market is projected to reach USD 9.6 billion by 2023 from an estimated USD 6.7 billion in 2018, at a CAGR of 7.4%.
E N D
MarketsandMarkets Presents Dental Biomaterials Market Insights on Scope and Growing Demands 2023 https://www.marketsandmarkets.com/Market-Reports/dental-biomaterial-market- 198160556.html
➢ [208 Pages Report] The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%. The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinicalprocessesisone of the major factors restrainingmarket growth. ➢ On the basis of type, the market is segmented into metallic, metal-ceramic, ceramic, polymeric, and natural dental biomaterials the metallic biomaterials segment accounted for the largest share in 2018. The large share of this segment can be attributed to the increasing penetration of dental implants and the wide applicationsof metallicbiomaterials indentistry. ➢ The market is categorized into implantology, prosthodontics, orthodontics, and other applications. In 2018, the implantology application segment accounted for the largest share of the market. The large share of this segment can be attributed to the increasing penetration of dental implants globally, high price and volume requirements of titanium used in manufacturing dental implants, rising incidence of dental diseases, increasing demand for cosmetic dentistry, growing dental tourism in emerging markets, and increasing disposable incomesindevelopingcountries. https://www.marketsandmarkets.com/Market-Reports/dental-biomaterial-market- 198160556.html
Early buyers will receive 10% customization on Reports. https://www.marketsandmarkets.com/Market-Reports/dental-biomaterial-market- 198160556.html
➢ The market is categorized into implantology, prosthodontics, orthodontics, and other applications. In 2018, the implantology application segment accounted for the largest share of the market. The large share of this segment can be attributed to the increasing penetration of dental implants globally, high price and volume requirements of titanium used in manufacturing dental implants, rising incidence of dental diseases, increasing demand for cosmetic dentistry, growing dental tourism in emerging markets, and increasing disposable incomesindevelopingcountries. ➢ Based on the end user, the market is segmented into dental implant and prosthetic manufacturers, dental laboratories, dental hospitals and clinics, and dental academies and research institutes. In 2018, the dental implant and prosthetic manufacturers segment accounted for the largest of the dental biomaterials market. The large share of this segment can be attributed to the increasing penetration of dental implants and prosthetics, growing adoption of CAD/CAM systems in dental clinics and laboratories, increasing number of dental practices,and the risingawareness on oral diseases. https://www.marketsandmarkets.com/Market-Reports/dental-biomaterial-market- 198160556.html
➢ Geographically, the global dental biomaterial market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, Europe held the largest share of this market, and this is primarily attributed to the growing geriatric population, increasing government expenditure on oral healthcare, higher adoption of the dental biomaterials to manufacture implants andother dental products, and growing number of dental hospitalsand clinics. ➢ The prominent players in the global market are Institut Straumann AG (Switzerland), Geistlich Pharma AG(Switzerland), Zimmer Biomet Holdings,Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals ,Inc. (Japan), VictrexPlc (UK), IvoclarVivadent AG(Principalityof Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGOMedicalGmbH (Germany),andCam BioceramicsB.V(Netherland). ➢ To speak to our analyst for a discussion on the above findings, click Speak to Analyst https://www.marketsandmarkets.com/Market-Reports/dental-biomaterial-market- 198160556.html
About MarketsandMarkets MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpointsaround revenues decisions. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. https://www.marketsandmarkets.com/Market-Reports/dental-biomaterial-market- 198160556.html
Contact Us Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 Email: sales@marketsandmarkets.com Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/ Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets https://www.marketsandmarkets.com/Market-Reports/dental-biomaterial-market- 198160556.html